Haemonetics Announces 2020 Annual Meeting Of Shareholders Will Be Conducted In Virtual Format

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) has announced that its 2020 Annual Meeting of Shareholders will be held virtually on July 21, 2020, at 8 a.m. Eastern Time. This decision is in response to the COVID-19 pandemic to ensure the health of participants. Only shareholders of record as of May 22, 2020 can attend the meeting by using a control number provided in their proxy materials. They are encouraged to vote prior to the meeting. Additional proxy materials have been filed with the SEC regarding voting and participation details.

Positive

• Transitioning to a virtual format ensures shareholder safety during the pandemic.
• Encouragement for early voting may increase shareholder engagement.

Negative

• None.

BOSTON, June 30, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced that its 2020 Annual Meeting of Shareholders (the "Annual Meeting") will be held exclusively in a virtual meeting format at the previously announced date and time of July 21, 2020, at 8 a.m. Eastern Time, in light of the public health impact of the coronavirus pandemic (COVID-19) and to support the health and well-being of the Company's shareholders, employees and directors. 

The Annual Meeting will be hosted via live audio webcast at http://www.meetingcenter.io/222479711. As described in the proxy materials for the Annual Meeting previously distributed, only shareholders of record at the close of business on May 22, 2020 are entitled to participate in the Annual Meeting. Shareholders of record will be admitted to the virtual Annual Meeting by entering the 15-digit control number found on their shareholder meeting notice or proxy card previously received from Computershare, along with the password: HAE2020. Shareholders who do not have their control number may contact Computershare Shareholder Services at 1-800-368-5948.

Shareholders who own in "street name" through a bank, broker or other intermediary will need to register in advance of the Annual Meeting by submitting to Computershare proof of their legal proxy reflecting their Company holdings along with the shareholder's name and email address. Such shareholders can obtain a legal proxy by contacting the bank, broker or other intermediary that holds their shares. All requests must be submitted to Computershare no later than 5 p.m. Eastern Time on July 16, 2020, either by email at legalproxy@computershare.com or by mail to Computershare, Haemonetics Legal Proxy, 462 S 4^th Street, Louisville, KY 40202.

The Company encourages eligible shareholders to vote on the proposals prior to the Annual Meeting using the instructions provided in the proxy statement previously distributed. The proxy card included with the proxy materials previously distributed may continue to be used to vote shares in connection with the Annual Meeting.

The Company has also filed additional proxy materials with the Securities and Exchange Commission for a Notice of Change of Location of the Annual Meeting that contain information regarding, among other things, how shareholders can vote and ask questions during the Annual Meeting. A copy of these materials are also available on the Company's Investor Relations website.

About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contact:   
Olga Guyette, Director-Investor Relations
(781) 356-9763
olga.guyette@haemonetics.com 

Media Contact:
Carla Burigatto, VP- Global Communications
(781) 348-7263
carla.burigatto@haemonetics.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-announces-2020-annual-meeting-of-shareholders-will-be-conducted-in-virtual-format-301086192.html

SOURCE Haemonetics Corporation

FAQ

When is Haemonetics' 2020 Annual Meeting of Shareholders?

The 2020 Annual Meeting of Shareholders for Haemonetics is scheduled for July 21, 2020, at 8 a.m. Eastern Time.

How can shareholders participate in the Haemonetics Annual Meeting?

Shareholders can participate by using a control number from their proxy materials to access the virtual meeting.

What is the reason for Haemonetics holding a virtual meeting?

The meeting is being held virtually to protect the health and well-being of shareholders due to the COVID-19 pandemic.

What must shareholders do to vote at the Haemonetics Annual Meeting?

Shareholders are encouraged to vote prior to the meeting using the instructions provided in the proxy statement.